MEDIGENE Trademark

Trademark Overview


On Tuesday, January 2, 1996, a trademark application was filed for MEDIGENE with the United States Patent and Trademark Office. The USPTO has given the MEDIGENE trademark a serial number of 75039069. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Sunday, September 26, 2021. This trademark is owned by MediGene GmbH. The MEDIGENE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

medicaments for the treatment of [ cardiac, ] cancer [ and metabolic ] diseases in human beings [ and animals ] ; [serums and recombinant proteins as vaccines against cancer and infectious diseases; test kits containing antibodies, enzymes, DNA and biochemical solutions for the testing of cardiac diseases, such as congestive heart failure, and cancer diseases, such as cervical and ovarian cancer, melanoma and other epithelial tumors in human beings and animals; diagnostic and therapeutic reagents, such as antibodies, DNA, enzymes and biochemical solutions for clinical medical laboratory use in the field of human and veterinary molecular biology, genetic engineering and bioengineering]

laboratory research and development of testing methods in the fields of human [ and veterinary ] molecular biology, genetic engineering and bioengineering, screening for pharmaceutically effective compounds
medigene

General Information


Serial Number75039069
Word MarkMEDIGENE
Filing DateTuesday, January 2, 1996
Status710 - CANCELLED - SECTION 8
Status DateSunday, September 26, 2021
Registration Number2240064
Registration DateTuesday, April 20, 1999
Mark Drawing5S07 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 28, 1998

Trademark Statements


Certificate of Correction for RegistrationIN THE STATEMENT, COLUMN 1, BEFORE LINE 1, MEDIGENE AG, (GERMANY CORPORATION), MARTINSRIED, MUNICH, GERMANY, BY CHANGE OF NAME FROM, SHOULD BE INSERTED.
Goods and Servicesmedicaments for the treatment of [ cardiac, ] cancer [ and metabolic ] diseases in human beings [ and animals ] ; [serums and recombinant proteins as vaccines against cancer and infectious diseases; test kits containing antibodies, enzymes, DNA and biochemical solutions for the testing of cardiac diseases, such as congestive heart failure, and cancer diseases, such as cervical and ovarian cancer, melanoma and other epithelial tumors in human beings and animals; diagnostic and therapeutic reagents, such as antibodies, DNA, enzymes and biochemical solutions for clinical medical laboratory use in the field of human and veterinary molecular biology, genetic engineering and bioengineering]
Goods and Serviceslaboratory research and development of testing methods in the fields of human [ and veterinary ] molecular biology, genetic engineering and bioengineering, screening for pharmaceutically effective compounds

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSunday, September 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSunday, September 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMEDIGENE AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMARTINSRIED, MUNICH
DE

Party NameMediGene GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressD-82152 Martinsried
DE

Party NameMediGene GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressD-82152 Martinsried
DE

Trademark Events


Event DateEvent Description
Sunday, September 26, 2021CANCELLED SEC. 8 (10-YR)
Friday, April 20, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, November 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 28, 2009REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, January 28, 2009REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, January 22, 2009ASSIGNED TO PARALEGAL
Thursday, January 15, 2009REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Thursday, January 15, 2009TEAS SECTION 8 & 9 RECEIVED
Thursday, July 19, 2007CASE FILE IN TICRS
Thursday, June 16, 2005REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, June 16, 2005ASSIGNED TO PARALEGAL
Wednesday, April 20, 2005REGISTERED - SEC. 8 (6-YR) FILED
Wednesday, April 20, 2005TEAS SECTION 8 RECEIVED
Tuesday, July 6, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 9, 2001CORRECTION UNDER SECTION 7 ¿ PROCESSED
Wednesday, August 23, 2000RESPONSE RECEIVED TO POST REG. ACTION
Wednesday, February 23, 2000POST REGISTRATION ACTION MAILED - SEC. 7
Friday, July 23, 1999SEC 7 REQUEST FILED
Tuesday, April 20, 1999REGISTERED-PRINCIPAL REGISTER
Tuesday, March 9, 1999Sec. 1(B) CLAIM DELETED
Friday, March 5, 1999NOTICE OF ALLOWANCE CANCELLED
Tuesday, October 20, 1998NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 1998PUBLISHED FOR OPPOSITION
Friday, June 26, 1998NOTICE OF PUBLICATION
Thursday, April 2, 1998APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 9, 1998CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 8, 1997NON-FINAL ACTION MAILED
Friday, March 28, 1997LETTER OF SUSPENSION MAILED
Friday, December 20, 1996CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 20, 1996NON-FINAL ACTION MAILED
Friday, June 14, 1996ASSIGNED TO EXAMINER